MDxHealth SA MDXH Stock
MDxHealth SA Price Chart
MDxHealth SA MDXH Financial and Trading Overview
| MDxHealth SA stock price | 0.6 USD |
| Previous Close | 0.76 USD |
| Open | 0.77 USD |
| Bid | 0.48 USD x 200 |
| Ask | 0.75 USD x 200 |
| Day's Range | 0.52 - 0.77 USD |
| 52 Week Range | 0.51 - 5.33 USD |
| Volume | 2.36M USD |
| Avg. Volume | 548.37K USD |
| Market Cap | 33.91M USD |
| Beta (5Y Monthly) | -510468.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.65 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.9 USD |
MDXH Valuation Measures
| Enterprise Value | 97.17M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.0784616 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.30558854 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.876 |
| Enterprise Value/EBITDA | -9.062 |
Trading Information
MDxHealth SA Stock Price History
| Beta (5Y Monthly) | -510468.06 |
| 52-Week Change | -69.79% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 5.33 USD |
| 52 Week Low | 0.51 USD |
| 50-Day Moving Average | 1.89 USD |
| 200-Day Moving Average | 3.27 USD |
MDXH Share Statistics
| Avg. Volume (3 month) | 548.37K USD |
| Avg. Daily Volume (10-Days) | 896.38K USD |
| Shares Outstanding | 51.36M |
| Float | 36.24M |
| Short Ratio | 1.07 |
| % Held by Insiders | 11.12% |
| % Held by Institutions | 48.68% |
| Shares Short | 910.29K |
| Short % of Float | 2.35% |
| Short % of Shares Outstanding | 1.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -29.89% |
| Operating Margin (ttm) | -26.66% |
| Gross Margin | 63.74% |
| EBITDA Margin | -9.66% |
Management Effectiveness
| Return on Assets (ttm) | -6.37% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 110.97M USD |
| Revenue Per Share (ttm) | 2.18 USD |
| Quarterly Revenue Growth (yoy) | 12.69% |
| Gross Profit (ttm) | 70.74M USD |
| EBITDA | -10722000 USD |
| Net Income Avi to Common (ttm) | -33177000 USD |
| Diluted EPS (ttm) | -0.65 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 43.15M USD |
| Total Cash Per Share (mrq) | 0.83 USD |
| Total Debt (mrq) | 105.88M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.633 |
| Book Value Per Share (mrq) | -0.388 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1049000 USD |
| Levered Free Cash Flow (ttm) | -15484000 USD |
Profile of MDxHealth SA
| Country | United States |
| State | N/A |
| City | Herstal |
| Address | CAP Business Center |
| ZIP | 4040 |
| Phone | 866 259 5644 |
| Website | https://mdxhealth.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 364 |
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Q&A For MDxHealth SA Stock
What is a current MDXH stock price?
MDxHealth SA MDXH stock price today per share is 0.6 USD.
How to purchase MDxHealth SA stock?
You can buy MDXH shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MDxHealth SA?
The stock symbol or ticker of MDxHealth SA is MDXH.
Which industry does the MDxHealth SA company belong to?
The MDxHealth SA industry is Diagnostics & Research.
How many shares does MDxHealth SA have in circulation?
The max supply of MDxHealth SA shares is 51.36M.
What is MDxHealth SA Price to Earnings Ratio (PE Ratio)?
MDxHealth SA PE Ratio is now.
What was MDxHealth SA earnings per share over the trailing 12 months (TTM)?
MDxHealth SA EPS is -0.65 USD over the trailing 12 months.
Which sector does the MDxHealth SA company belong to?
The MDxHealth SA sector is Healthcare.
MDxHealth SA MDXH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}